MME advised KARL STORZ on the acquisition of the Anklin AG
We are delighted to announce that the family-owned MedTech company KARL STORZ successfully completed the acquisition of its long-standing local distributor ANKLIN AG to further expand direct sales in Switzerland. This acquisition brings KARL STORZ closer to its customers and their individual needs regarding products and services in the MedTech industry. The majority of ANKLIN’s business involves distributing and supporting KARL STORZ products, and it holds a strong share of this market. KARL STORZ will now benefit directly from the excellent market knowledge of ANKLIN employees as well as client relationships. KARL STORZ’s acquisition of ANKLIN also allows it to further strengthen relationships with healthcare partners in Switzerland, enabling it to meet their individual needs and deliver specialized advice on increasingly complex solutions. For further information please refer to KARL STORZ Further Expands Direct Sales with Acquisition in Switzerland | KARL STORZ Endoskope.
Founded in 1954 in Tuttlingen, Germany, KARL STORZ is a global leader in endoscopy and medical instruments. The family-owned company, now in its third generation, employs 9’400 people across more than 40 countries. KARL STORZ offers a diverse portfolio of 13’000 products for both human and veterinary medicine. In 2023, the company reported sales of 2.17 billion euros. KARL STORZ operates production sites in Germany, the USA, Switzerland, and Estonia.
Founded in 1948 and headquartered in Reinach BL, Switzerland, ANKLIN is a distributor of high-precision medical instruments and devices in the field of endoscopy for human and veterinary medicine. Known for its exceptional service quality, ANKLIN has established itself as a very well-known brand in Switzerland. With a successful history of collaboration with KARL STORZ, ANKLIN has continually advanced its offerings to meet the evolving needs of the medical endoscopes industry. The company serves the entire Swiss market in all language regions and employs a dedicated team of around 70 specialists.
MME advised KARL STORZ on all legal matters related to this transaction.
The MME team was led by Alex Enzler (Partner, Corporate/M&A) and included Martina Kim (Senior Associate, Corporate/M&A), Jonatan Baier (Partner, Regulatory MedTech), Luca Hitz (Partner, Competition), Simone Dubs (Senior Associate, Employment) and Marc Klingelfuss (Junior Associate).
We congratulate our long-standing client KARL STORZ on this important acquisition to further expand direct sales in Switzerland and look forward to following its continued success!